Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Return on Equity (2016 - 2023)

Historic Return on Equity for Aethlon Medical (AEMD) over the last 12 years, with Q4 2023 value amounting to 0.28%.

  • Aethlon Medical's Return on Equity rose 4300.0% to 0.28% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.28%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 1.17% for FY2024, which is 4300.0% down from last year.
  • Aethlon Medical's Return on Equity amounted to 0.28% in Q4 2023, which was up 4300.0% from 0.45% recorded in Q3 2023.
  • Aethlon Medical's Return on Equity's 5-year high stood at 0.28% during Q4 2023, with a 5-year trough of 13.45% in Q3 2019.
  • Over the past 5 years, Aethlon Medical's median Return on Equity value was 0.67% (recorded in 2022), while the average stood at 1.6%.
  • As far as peak fluctuations go, Aethlon Medical's Return on Equity tumbled by -123300bps in 2019, and later skyrocketed by 130500bps in 2020.
  • Over the past 5 years, Aethlon Medical's Return on Equity (Quarter) stood at 3.06% in 2019, then skyrocketed by 81bps to 0.59% in 2020, then surged by 31bps to 0.41% in 2021, then plummeted by -74bps to 0.71% in 2022, then soared by 61bps to 0.28% in 2023.
  • Its last three reported values are 0.28% in Q4 2023, 0.45% for Q3 2023, and 0.64% during Q2 2023.